Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

Share Price is delayed by 15 minutes
Get Live Data
139.50    0.00 (0.00%)
Bid:
137.00
Ask:
142.00
Spread: 5.00 (3.65%)
Market Cap: £78.87m
MVI Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Val. Share Chart

Net Asset Values

16 Jul 2024 11:00

RNS Number : 5835W
Marwyn Value Investors Limited
16 July 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

 

LEI: 213800L5751QTTVEA774

16 July 2024

 

Marwyn Value Investors Limited

Net Asset Values

 

The board of directors of Marwyn Value Investors Limited (the "Company") today announces the following estimated net asset value ("NAV") information, based on the estimated value of its interests in Marwyn Value Investors L.P. as at 5 July 2024:

 

 

Ordinary Shares

 

The estimated NAV per Ordinary Share is £1.861. Based upon the Company's indirect investments, the estimated allocation of the Ordinary Share NAV is:

 

Ordinary Shares

Total Value (£m)1

NAV/pence per Ordinary Share

% of NAV

Investment Portfolio

 

 

 

Quoted investments

AdvancedAdvT

22.6

40.7

21.9%

MAC Alpha

1.0

1.8

1.0%

Marwyn Acquisition Company II

21.5

38.8

20.9%

Marwyn Acquisition Company III

5.9

10.6

5.7%

Zegona Communications

12.4

22.3

12.0%

450

5.1

9.2

4.9%

Unquoted investments

Le Chameau2

28.4

51.2

27.5%

Palmer Street

6.4

11.5

6.2%

Total Value

103.2

186.0

100.0%

Cash3

9.4

16.9

9.1%

Other assets / liabilities

(9.4)

(16.9)

(9.1)%

Net Asset Value

103.3

186.1

100.0%

 

2016 Realisation Shares

 

The estimated NAV per 2016 Realisation Share is £4.147. Based upon the Company's indirect investments, the estimated allocation of the 2016 Realisation Share NAV is:

 

2016 Realisation Shares

Total Value (£m)1

NAV/pence per 2016 Realisation Share

% of NAV

Investment Portfolio

Quoted investments

Zegona Communications

0.2

31.3

7.5%

Unquoted investments

Le Chameau2

2.4

350.5

84.5%

Total Value

2.6

381.8

92.1%

Cash

0.7

108.8

26.2%

Other assets / liabilities

(0.5)

(75.9)

(18.3)%

Net Asset Value

2.8

414.7

100.0%

 

 

2021 Realisation Shares

 

The estimated NAV per 2021 Realisation Share is £2.081. Based upon the Company's indirect investments, the estimated allocation of the 2021 Realisation Share NAV is:

 

2021 Realisation Shares

Total Value (£m)1

NAV/pence per 2021 Realisation Share

% of NAV

Investment Portfolio

Quoted investments

AdvancedAdvT

0.14

39.5

19.0%

Marwyn Acquisition Company II

0.14

37.6

18.1%

Marwyn Acquisition Company III

0.06

17.1

8.2%

Zegona Communications

0.08

21.4

10.3%

450

0.03

8.9

4.3%

Unquoted investments

Le Chameau2

0.18

49.6

23.8%

Total Value

0.63

174.1

83.7%

Cash3

0.18

50.4

24.2%

Other assets / liabilities

(0.06)

(16.4)

(7.9)%

Net Asset Value

0.75

208.1

100.0%

 

Notes

1Portfolio investments are held at fair value in accordance with International Financial Reporting Standards ("IFRS"). Quoted investments with sufficient volume and frequency of trading to constitute an 'active market' under IFRS are held at their listed price on the valuation date. Unquoted investments, and quoted investments where there is no active market, are valued in accordance with International Private Equity and Venture Capital guidelines on a quarterly basis or whenever there is a material change in the investment which would indicate a significant change in valuation.

2The investment in Le Chameau is held through Silvercloud Holdings Limited ("Silvercloud"), with the value allocated to Le Chameau being the value attributable to each share class of Marwyn Value Investors L.P.'s holding in Silvercloud.

3Includes cash to be received from the repurchase of securities in Marwyn Acquisition III Limited, as announced by the Company on 12 July 2024.

 

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

 

Enquiries to:

marwyn@aztecgroup.co.uk

Aztec Financial Services (Jersey) Limited

Aztec Group House

PO Box 730IFC 6, The EsplanadeSt. HelierJersey JE4 0QH

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGIGDRDDBDGSL
Date   Source Headline
8th Dec 202511:00 amRNSNet Asset Values
2nd Dec 20251:10 pmRNSNet Asset Value - 2021 Realisation Shares
2nd Dec 20251:08 pmRNSNet Asset Value - 2016 Realisation Shares
2nd Dec 20251:06 pmRNSNet Asset Value - Ordinary Shares
24th Nov 202511:00 amRNSNet Asset Values
17th Nov 202511:00 amRNSNet Asset Values
10th Nov 202511:00 amRNSNet Asset Values
4th Nov 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Nov 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Nov 202510:00 amRNSNet Asset Value - Ordinary Shares
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSInterim Dividend to Ordinary Shareholders
27th Oct 202511:00 amRNSNet Asset Values
20th Oct 202511:00 amRNSNet Asset Values
20th Oct 20257:00 amRNSShare Dealings
14th Oct 202511:00 amRNSNet Asset Values
13th Oct 20253:10 pmRNSNet Asset Value - 2021 Realisation Shares
13th Oct 20253:05 pmRNSNet Asset Value - 2016 Realisation Shares
13th Oct 20253:00 pmRNSNet Asset Value - Ordinary Shares
9th Oct 20257:43 amRNSInvestment Update - MAC III / Palmer
7th Oct 20257:05 amRNSInvestment Update – 450 / Silvercloud
6th Oct 20257:05 amRNSAvril Palmer-Baunack appointed MAC Alpha Chairman
30th Sep 20257:00 amRNSUnaudited Interim Results 2025
22nd Sep 202511:00 amRNSNet Asset Values
15th Sep 202511:00 amRNSNet Asset Values
8th Sep 202511:00 amRNSNet Asset Values
4th Sep 20259:18 amRNSNotification of Major Interests in Shares
2nd Sep 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Sep 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Sep 202510:00 amRNSNet Asset Value - Ordinary Shares
18th Aug 202511:00 amRNSNet Asset Values
11th Aug 202511:00 amRNSNet Asset Values
4th Aug 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Aug 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Aug 202510:00 amRNSNet Asset Value - Ordinary Shares
31st Jul 20257:00 amRNSInterim Dividend to Ordinary Shareholders
21st Jul 202511:00 amRNSNet Asset Values
15th Jul 202511:00 amRNSNet Asset Values
14th Jul 202512:10 pmRNSNet Asset Value - 2021 Realisation Shares
14th Jul 202512:05 pmRNSNet Asset Value - 2016 Realisation Shares
14th Jul 202512:00 pmRNSNet Asset Value - Ordinary Shares
23rd Jun 202511:00 amRNSNet Asset Values
16th Jun 202511:00 amRNSNet Asset Values
11th Jun 202511:55 amRNSNotification of Major Interests in Shares
9th Jun 202511:00 amRNSNet Asset Values
3rd Jun 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
3rd Jun 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
3rd Jun 202510:00 amRNSNet Asset Value - Ordinary Shares
27th May 202511:00 amRNSNet Asset Values
19th May 202511:00 amRNSNet Asset Values

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.